Definition
Cell therapy involves delivering functional cells (e.g., immune or stem cells) into patients to treat disease. These therapies can be autologous (from the patient) or allogeneic (from a donor), and are widely applied in cancer, autoimmune disorders, and genetic diseases.
Clinical Value
Cell-based therapies, including CAR-T for hematologic cancers, TIL for solid tumors, and MSCs for regenerative medicine, are rapidly advancing and represent a cornerstone of precision medicine.
OranssiBio Advantages
- 01
Extensive experience in cell therapy projects including CAR-T, NK, iPSC, and MSC platforms - 02
Fully closed, automated cell processing in GMP-compliant cleanroom environments - 03
End-to-end services from cell line development and process optimization to GMP release and CMC documentation - 04
In-depth analytical capabilities for identity, expansion, viability, and function
Service Highlights
Autologous and allogeneic process development and optimization
Process scale-up and aseptic production infrastructure
CMC document drafting and regulatory consulting
Cell banking, authentication, and storage management
Functional testing for CAR/TCR expression, cytotoxicity, and proliferation
Key Specifications
| Technical Specifications | Technical Parameters |
|---|---|
| Supported cell types | CAR-T, NK, iPSC, TIL, MSC, etc. |
| Batch size | scalable to billions of cells |
| Analytical readouts | viability, purity, phenotype, functional assays |
| Project scope | R&D – Phase I/II/III – Commercial |
